Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
0.8070
+0.0020 (0.25%)
At close: Mar 18, 2026, 4:00 PM EDT
0.7653
-0.0417 (-5.17%)
After-hours: Mar 18, 2026, 7:58 PM EDT
Beyond Air Employees
Beyond Air had 61 employees as of March 31, 2025. The number of employees decreased by 46 or -42.99% compared to the previous year.
Employees
61
Change (1Y)
-46
Growth (1Y)
-42.99%
Revenue / Employee
$113,508
Profits / Employee
-$508,213
Market Cap
8.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 61 | -46 | -42.99% | 61 | 0 |
| Mar 31, 2024 | 107 | 9 | 9.18% | 107 | 0 |
| Mar 31, 2023 | 98 | 36 | 58.06% | 98 | 0 |
| Mar 31, 2022 | 62 | 21 | 51.22% | 62 | 0 |
| Mar 31, 2021 | 41 | 18 | 78.26% | 41 | 0 |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vivos Therapeutics | 262 |
| AVITA Medical | 226 |
| Lifeward | 80 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| PAVmed | 39 |
| Movano | 32 |
| Tenon Medical | 27 |
XAIR News
- 1 day ago - Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial - GlobeNewsWire
- 26 days ago - Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections - GlobeNewsWire
- 4 weeks ago - Beyond Air, Inc. (XAIR) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 2 months ago - XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire
- 4 months ago - Beyond Air® Announces Transition of Chief Financial Officer - GlobeNewsWire
- 4 months ago - Beyond Air, Inc. (XAIR) Q2 2026 Earnings Call Transcript - Seeking Alpha